Bacterial Sepsis: Clinical Trials

6 trials for Bacterial Sepsis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 2 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 1, Withdrawn 1
Phase 11Terminated 1

Follow Bacterial Sepsis: new trials by email Literature Review of Bacterial Sepsis trials Research Report on Bacterial Sepsis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Monitoring of Beta-lactams in Critically Ill Patients With Sepsis
Individualized dosing of beta-lactam antibiotics based on therapeutic monitoring - Bacterial Sepsis
Not applicableNot yet recruitingComplexo Hospitalario Universitario de A Coruña1982026-01-012025-12-08
Study and Role of Inflammasome in Platelet Activation During Bacterial And/or Viral Sepsis
Bacterial Sepsis
RecruitingCentre Hospitalier Universitaire de la Guadeloupe1712022-11-302024-10-24
The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront
Decortication - Pleural Empyema, Tuberculosis (TB)
CompletedUniversity of Health Sciences Lahore3502022-01-012025-09-15
Blood Volume Assessment in COVID-19 and Bacterial Sepsis
BVA-100, Transpulmonary Thermodilution (TPTD), Sublingual Microcirculation - Covid19, Acute Respiratory Distress Syndrome
CompletedNYU Langone Health392020-08-012023-09-21
Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial Septic Shock
low-carbohydrate nutrition, Standard enteral nutrition - Bacterial Sepsis
Not applicableWithdrawnYale University2018-01-082021-11-26
Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant
CPG 7909, J5-OMP Vaccine, Placebo - Bacterial Sepsis
Phase 1TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)202011-11-012014-01-31

Narrower conditions

Sepsis (3)  ·  Bacterial Infections (1)  ·  COVID-19 (1)  ·  Empyema, Pleural (1)  ·  Respiratory Distress Syndrome (1)  ·  Tuberculosis (1)

Broader conditions

Infections (5)  ·  Inflammation (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Systemic Inflammatory Response Syndrome (3)  ·  Bacterial Infections and Mycoses (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Empyema (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Lung Diseases (1)

Interventions

Cerebral Decortication (1)  ·  ProMune (1)

Sponsors

Centre Hospitalier Universitaire de la Guadeloupe (1)  ·  Complexo Hospitalario Universitario de A Coruña (1)  ·  NYU Langone Health (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  University of Health Sciences Lahore (1)  ·  Yale University (1)

Countries

United States (3)  ·  Guadeloupe (1)  ·  Pakistan (1)  ·  Spain (1)

Top investigators

Andrew Wang, MD PhD (1)  ·  Jan Bakker, MD, PhD (1)  ·  Muhammad Shoaib Nabi, Professor of Thoracic Surgery (1)

Results publications

PMID 26514420